From: High prevalence of thrombophilic risk factors in patients with central retinal artery occlusion
Parameter | Patients n = 126 | Controls n = 107 | p-value |
---|---|---|---|
Demographic characteristics | |||
Age, years | 55.7 (53.7–57.7) | 53.7 (51.9–55.5) | 0.1 |
Sex, male, n (%) | 66 (52.4%) | 56 (52.3%) | 0.9 |
Body mass index, kg/m2 | 26.6 (25.5–28.3) | 26.4 (24.2–27.9) | 0.1 |
Clinical characteristics | |||
Hypertension, n (%) | 49 (38.9%) | 27 (25.2%) | 0.038* |
Diabetes mellitus, n (%) | 24 (19.0%) | 9 (8.4%) | 0.012* |
Hypercholesterolemia, n (%) | 85 (67.5%) | 46 (43.0%) | < 0.001* |
Obesity/overweight, n (%) | 103 (81.7%) | 65 (60.7%) | < 0.001* |
Smoking habit, n (%) | 47 (37.3%) | 23 (21.5%) | 0.015* |
Positive family history of CVD, n (%) | 46 (36.5%) | 20 (18.7%) | 0.004* |
Laboratory tests | |||
Hemoglobin, g/dl | 14.5 (13.6–15.4) | 13.9 (12.8–14.8) | < 0.001* |
White blood cells, 103/µL | 6.8 (5.3–7.9) | 6.1 (5.0–7.1) | 0.011* |
Blood platelets, 103/µL | 228 (190–276) | 228 (198–278) | 0.86 |
Glucose, mmol/l | 5.7 (4.9–6.1) | 5.4 (4.9–5.8) | 0.10 |
Total cholesterol, mmol/l | 5.4 (4.9–5.9) | 5.0 (4.6–5.5) | < 0.001* |
High-density lipoprotein cholesterol, mmol/l | 1.2 (1.1–1.4) | 1.4 (1.2–1.6) | < 0.001* |
Low-density lipoprotein cholesterol, mmol/l | 3.2 (2.9–3.7) | 3.1 (2.8–3.4) | 0.13 |
Triglycerides, mmol/l | 1.8 (1.4–2.1) | 1.7 (0.9–1.9) | < 0.001* |
Creatinine, µmol/l | 88.3 (78.0–98.0) | 79.2 (69.3–92.1) | < 0.001* |
C-reactive protein, mg/l | 4.8 (3.6–6.5) | 2.8 (1.8–3.9) | < 0.001* |